REGENTIS BIOMATERIALS (RGNT) Chief Accounting Officer files initial Form 3

Rhea-AI Filing Summary

REGENTIS BIOMATERIALS LTD. Chief Accounting Officer Arie Gordashnikov filed an initial insider ownership report on Form 3. This filing establishes his status as an executive officer of the company and provides the baseline disclosure of his position for future insider trading reports. No transactions are reported.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gordashnikov Arie

(Last) (First) (Middle)

C/O REGENTIS BIOMATERIALS LTD.

60 MEDINAT HAYEHUDIM

(Street)

HERZLIYA 4676652

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
REGENTIS BIOMATERIALS LTD. [ RGNT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Arie Gordashnikov	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the REGENTIS BIOMATERIALS (RGNT) Form 3 for Arie Gordashnikov disclose?

It discloses that Arie Gordashnikov is a Chief Accounting Officer of REGENTIS BIOMATERIALS and is now a reporting insider. The Form 3 serves as his initial ownership statement, providing a baseline for any future Form 4 or Form 5 transaction reports.

Does the RGNT Form 3 for Arie Gordashnikov show any share purchases or sales?

No, the Form 3 for Arie Gordashnikov shows no reported transactions. It is an initial ownership filing, meaning it mainly registers him as an insider rather than documenting buys, sells, or other changes in his holdings at this time.

Why is a Form 3 filing by RGNT’s Chief Accounting Officer important for investors?

A Form 3 filing is important because it identifies the executive as an SEC-reporting insider. Once on record, any future trades by the Chief Accounting Officer in REGENTIS BIOMATERIALS securities must be reported, improving transparency into insider activity for investors and regulators.

What insider role does Arie Gordashnikov hold at REGENTIS BIOMATERIALS (RGNT)?

Arie Gordashnikov is disclosed as the Chief Accounting Officer of REGENTIS BIOMATERIALS. This officer role makes him a reporting person under SEC rules, requiring public disclosure of his initial ownership on Form 3 and subsequent trading activity on future forms.

Does the RGNT Form 3 indicate that Arie Gordashnikov is a 10% owner?

No, the filing indicates that Arie Gordashnikov is not a ten percent owner. He is classified as an officer, specifically Chief Accounting Officer, which triggers reporting obligations but does not imply that he holds a large equity stake in the company.